Loading...
ROCO
4173
Market cap41mUSD
Oct 08, Last price  
17.55TWD
1D
2.03%
1Q
-3.04%
Jan 2017
4.09%
IPO
-61.72%
Name

Arich Enterprise Co Ltd

Chart & performance

D1W1MN
ROCO:4173 chart
P/E
15.08
P/S
0.85
EPS
1.16
Div yield, %
6.77%
Shrs. gr., 5y
2.70%
Rev. gr., 5y
4.33%
Revenues
1.55b
+19.20%
1,112,150,0001,251,395,000945,661,0001,018,023,0001,140,078,0001,297,767,0001,546,999,000
Net income
87m
-7.53%
60,628,00047,249,00055,305,00062,617,00076,532,00093,860,00086,792,000
CFO
-1.91b
L
0559,557,000336,065,000139,226,000-274,449,0002,150,107,000-1,909,506,000
Dividend
Apr 16, 20261.04 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1969 and headquartered in New Taipei City, Taiwan, Arich Enterprise Co., Ltd. specializes in the marketing, promotion, and distribution of pharmaceutical products across Taiwan. Their portfolio includes both prescribed medications and over-the-counter drugs. Furthermore, the company extends its services to include a full suite of logistics operations for the pharmaceutical sector. These encompass inventory management for drug manufacturers, systematic distribution, handling of customer concerns, national transportation, and secure warehousing. Arich serves a diverse customer base, including hospitals, medical clinics, independent pharmacies, large retail drugstore chains, and hypermarkets.

Key people

Chairman of the Board · since 2024
Yiyan Lu
Chief Financial Officer · since 2015
Wen Chuan Hung
General Manager · since 2026
Yi Wen Lin
Corporate Governance Officer · since 2022
Director · since 2024
Wenlin Su
Director
Director
Xianzheng Zhang
Director · since 2021
Director · since 2024
Detai Dong
Independent Director · since 2021
Independent Director · since 2021
Shuisheng Xu
Independent Director · since 2021
IPO date
Jul 10, 2012
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT